| Literature DB >> 27276184 |
Claudio Bs Oliveira1, Ywlliane Sr Meurer1,2, Joelma Ma Andrade1, Maria Esm Costa3, Milena Mc Andrade1,4, Letícia A Silva4, Daniel Cf Lanza3, Ricardo Wa Vítor4, Valter F Andrade-Neto1.
Abstract
Toxoplasma gondii is the causative protozoan agent of toxoplasmosis, which is a common infection that is widely distributed worldwide. Studies revealed stronger clonal strains in North America and Europe and genetic diversity in South American strains. Our study aimed to differentiate the pathogenicity and sulfadiazine resistance of three T. gondii isolates obtained from livestock intended for human consumption. The cytopathic effects of the T. gondii isolates were evaluated. The pathogenicity was determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) using a CS3 marker and in a rodent model in vivo. Phenotypic sulfadiazine resistance was measured using a kinetic curve of drug activity in Swiss mice. IgM and IgG were measured by ELISA, and the dihydropteroate synthase (DHPS) gene sequence was analysed. The cytopathic effects and the PCR-RFLP profiles from chickens indicated a different infection source. The Ck3 isolate displayed more cytopathic effects in vitro than the Ck2 and ME49 strains. Additionally, the Ck2 isolate induced a differential humoral immune response compared to ME49. The Ck3 and Pg1 isolates, but not the Ck2 isolate, showed sulfadiazine resistance in the sensitivity assay. We did not find any DHPS gene polymorphisms in the mouse samples. These atypical pathogenicity and sulfadiazine resistance profiles were not previously reported and served as a warning to local health authorities.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27276184 PMCID: PMC4909038 DOI: 10.1590/0074-02760150459
Source DB: PubMed Journal: Mem Inst Oswaldo Cruz ISSN: 0074-0276 Impact factor: 2.743
Fig. 1: RAW 264.7 cell cultures infected with Ck2 (A) or Ck3 (B). Frames and arrows highlight extracellular tachyzoites.
Fig. 2: RAW 264.7 cell cultures infected with Ck2 (A-B) or Ck3 (C-D). Images A-B were taken 17.5 h and 20 h post-infection. Images C-D were taken 22.5 h and 23 h post-infection.
Fig. 3: survival curve for the assessment of pathogenicity. (A) Swiss female mice (n = 3) after infection with 5 x 104 Ck2, Ck3 or Pg1GToxoplasma gondii tachyzoites or the RH, ME49 or VEG clonal lineage controls; (B) Swiss female mice (n = 3) after infection with five cysts of the Ck2, Ck3, Pg1 or ME49 strain; (C) C57BL/6 female mice (n = 3) after infection with five cysts of the Ck2, Ck3, Pg1 or ME49 strain (***p < 0.001; **p < 0.01; *p < 0.05).
Fig. 4: serum IgM (A) and IgG (B) levels in C57BL/6 female mice (n = 3) infected with five cysts of the Ck2 or ME49 strain (***p < 0.001; **p < 0.01; *p < 0.05).
Fig. 5: percent survival of Swiss mice infected with five cysts of the Ck2 (A), Ck3 (B) or Pg1 (C) isolates of Toxoplasma gondiiand treated with different concentrations of sulfadiazine (100, 200 or 300 mg/kg/day) for six days.